Common Stock, Shares, Outstanding of Taysha Gene Therapies, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Taysha Gene Therapies, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Taysha Gene Therapies, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 273,915,373, a 34% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Taysha Gene Therapies, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 273,915,373 +68,972,067 +34% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 272,730,060 +71,348,610 +35% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 205,054,570 +18,036,295 +9.6% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 204,943,306 +17,983,113 +9.6% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 204,943,306 +17,983,113 +9.6% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 201,381,450 +136,948,813 +213% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 187,018,275 +123,544,926 +195% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 186,960,193 +123,752,686 +196% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 186,960,193 +145,784,254 +354% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 64,432,637 +23,412,551 +57% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 63,473,349 +24,999,404 +65% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 63,207,507 +24,733,562 +64% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 41,175,939 +2,701,994 +7% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 41,020,086 +2,628,921 +6.8% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 38,473,945 +712,510 +1.9% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 38,473,945 +712,510 +1.9% 31 Dec 2021 10-K 28 Mar 2023 2022 FY
Q3 2021 38,473,945 +712,510 +1.9% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 38,391,165 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 37,761,435 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 37,761,435 +26,866,436 +247% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 37,761,435 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q4 2019 10,894,999 31 Dec 2019 10-K 03 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.